Price control crackdown reveals 2,373 offences and RM11.6m in seizures.
Read More
Aurobindo Pharma shares: Are They the Best Investment Now?
Aurobindo Pharma shares are in focus after USFDA approval for Perampanel tablets, raising investor interest and market potential.
Read More
Fexuclu launch in Indonesia: Proven benefits for patients
Fexuclu launch in Indonesia marks a significant expansion of Daewoong in Southeast Asia.
Read More
Lupin Modafinil approval: Is it the Worst News for Investors?
Lupin Modafinil approval has raised concerns as share prices dip. What does this mean for investors?
Read More